Risk factors and current state of therapy for anemia after kidney transplantation

Y Tang, J Guo, J Zhou, Z Wan, J Li, T Qiu - Frontiers in Medicine, 2024 - frontiersin.org
Post-transplant anemia is one of the most common complications in kidney transplant
recipients, severely affecting patient prognosis and quality of life, and is an independent …

[HTML][HTML] Efficacy and safety of roxadustat in the treatment of renal allograft anemia patients: a case series

J Li, K Ma, L Wang, H Qi, J Lv, Y Rao… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: To observe the efficacy and safety of roxadustat, an inhibitor of proline
hydroxylase, in renal allograft anemia patients. Methods: This prospective study collected …

Intravenous immunoglobulin in kidney transplantation: Mechanisms of action, clinical applications, adverse effects, and hyperimmune globulin

Y Hou, S Chang, S Chen, W Zhang - Clinical Immunology, 2023 - Elsevier
Intravenous immunoglobulin (IVIG) has been developed for over 40 years. The mechanisms
of action of IVIG are complex and diverse, and there may be multiple mechanisms that …

Pre-existing intrarenal parvovirus b19 infection may relate to antibody-mediated rejection in pediatric kidney transplant patients

N Bertazza Partigiani, S Negrisolo, A Carraro… - International Journal of …, 2023 - mdpi.com
Viral infections can lead to transplant dysfunction, and their possible role in rejection is
described. In total, 218 protocol biopsies performed in 106 children at 6, 12 and 24 months …

Foscarnet therapy for pure red cell aplasia related to human parvovirus B19 infection in kidney transplant recipients: a preliminary exploration

Y Yu, R Bao, J Lyu, J Wu, J Chen… - Infection and Drug …, 2021 - Taylor & Francis
Background Parvovirus B19-associated pure red cell aplasia (PVB19-PRCA) is an
uncommon but serious complication after kidney transplantation. Currently, intravenous …

[HTML][HTML] Clinical utility of immune function based on IFN-γ monitoring of lymphocyte subsets for parvovirus B19 infection in renal recipients

QQ Zhang, W Zhang, F Wang, S Chen… - Infection, Genetics and …, 2022 - Elsevier
Background There should be a heightened index of suspicion for Parvovirus B19 (PVB19)-
related anemia in organ transplant recipients. Thus far, there is no consensus or …

[HTML][HTML] ABO-incompatible living donor kidney transplantation failure due to acute blood group antibody-dependent rejection triggered by human parvovirus B19 …

L Dai, X Wang, Y Hou, Z Zou, S Chen… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background With the improvement of immunosuppressive regimens, the success rate and
availability of ABO-incompatible (ABO-i) kidney transplantation (KT) have gradually …

Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT

X Zhou, P Jiang, L Gao, J Yang, Y Cai, Y Tong… - Annals of …, 2022 - Springer
Abstract Parvovirus B19 (PvB19) infection and PvB19 related pure red cell aplasia (PRCA)
in recipients with allogeneic hematopoietic stem cell transplantation have been reported …

Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant

M Sabanci, M Taşdemir, B Öksüz, Y Altuner Torun… - Pediatric …, 2024 - Springer
A 13-year-old girl who had a kidney transplant four weeks prior presented with a 10-day
history of fatigue, paleness, and headache. On physical examination, tachycardia and …

肾移植受者人类微小病毒B19 感染临床诊疗技术规范(2022 版).

金海龙, 石炳毅 - Organ Transplantation/Qi Guan Yi Zhi, 2022 - search.ebscohost.com
肾移植受者长期使用免疫抑制剂, 导致其免疫功能低下, 容易伴发各种病原体感染.
近年来随着人类微小病毒B19 (HPV-B19) 感染的检测技术发展和肾移植手术的增多 …